Developer docs
API playgroundTry for free, no card

Search company profiles

Biomonde

Full company profile

uuid000e6r6

Namestring
Biomonde
Websiteurl
biomonde.com
Company typeenum
Private
Founded yearint
2004
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBridgend, United Kingdom
HQ citystring
Bridgend
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
biological wound care, larval debridement therapy, wound bed preparation, biosurgical wound treatment, natural wound healing
Industry2 codes
PRIMARYHLAHALAE
Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
SECONDARYHLAAAGAG
Wound Healing & Skin Regeneration (advanced dressings, skin substitutes)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Biosurgical Wound Care Products
Social media profiles1 record
Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Biomonde produces a precise, natural, and sustainable biological treatment aimed at wound bed preparation as a step toward wound healing. The company develops and supplies this therapy as its core commercial offering, manufactured and distributed from its Bridgend, United Kingdom facility. Its operations are oriented around a single therapeutic platform rooted in biological, nature-derived mechanisms rather than conventional pharmaceuticals.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Natural Biological Wound Care Treatment
CategoryBiosurgical Wound Care
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Diversified medical technology company whose Integra Dermal Regeneration Template and wound-care franchise overlap with Biomonde's biologic wound-healing focus. Comparable as a competitor in advanced and regenerative wound therapies.

TypeBroad incumbent
Description

Global wound care and ostomy management company whose Biatain and Comfeel lines compete in the chronic-wound category. Comparable to Biomonde for addressing the same clinician and patient population in wound bed preparation and downstream healing.

TypeBroad incumbent
Description

Established wound care and surgical solutions company best known for Mepitel, Mepilex, and other advanced wound dressings. Comparable to Biomonde for serving the same hospital wound-care buying pathway, including wound bed preparation step.

TypeBroad incumbent
Description

Large diversified health-care business (recently spun off as Solventum) with a significant advanced wound-care portfolio. Comparable to Biomonde for providing wound-care solutions used in the same clinical pathway, including wound bed preparation and active healing.

TypeBroad incumbent
Description

Specialist medical products company with a strong advanced wound care and ostomy franchise (Aquacel, Foam dressings). Comparable to Biomonde as a chronic-wound portfolio provider where wound bed preparation is a routine precursor to ConvaTec's dressing usage.

TypeOthers
Description

Major medical products distributor and manufacturer whose Cardinal Health wound-care portfolio reaches the same hospital and post-acute customers Biomonde targets. Comparable as a channel competitor and adjacent wound-care supplier, rather than as a direct biologic-therapy rival.

TypeDirect peer
Description

Regenerative medicine company selling biologic wound-care products (e.g., Apligraf, Dermagraft) used in chronic wound healing. Directly comparable to Biomonde for offering biologic/living-cell therapies targeted at wound healing rather than only dressings.

8Medline Industries
TypeBroad incumbent
Description

Large private medical supplies manufacturer and distributor with an advanced wound-care line sold to hospitals and post-acute providers. Comparable to Biomonde as a competitor in the wound-care supply chain serving clinicians preparing wound beds.

TypeDirect peer
Description

Regenerative medicine company focused on placental tissue allografts for wound care and surgical recovery. Directly comparable to Biomonde for delivering biologic, tissue-based therapies used in wound management and wound bed preparation.

TypeBroad incumbent
Description

Global medical device company with a leading advanced wound management portfolio (dressings, negative pressure wound therapy, biologics). Comparable to Biomonde as a wound-care provider addressing the same clinical use cases (including wound bed preparation) at much larger scale.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biomonde

Biosurgical Wound Care Productsbiomonde.com

Biomonde firmographics

Firmographics
Name
Biomonde
Website
https://biomonde.com
Company type
Private
Founded year
2004
Headcount range
11–50 employees
Ownership category
akta.pro rank

Biomonde industry classification

Industry
Product category
Biosurgical Wound Care Products
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAHALAE
Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
SECONDARYHLAAAGAG
Wound Healing & Skin Regeneration (advanced dressings, skin substitutes)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

  • Biological wound care
  • Larval debridement therapy
  • Wound bed preparation
  • Biosurgical wound treatment
  • Natural wound healing

Where Biomonde is headquartered

Location

Headquarters

HQ city
Bridgend
HQ country
United Kingdom
HQ region
Europe

Markets served

Biomonde business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Biomonde product offering

Product offering

Core offering

Biomonde produces a precise, natural, and sustainable biological treatment aimed at wound bed preparation as a step toward wound healing. The company develops and supplies this therapy as its core commercial offering, manufactured and distributed from its Bridgend, United Kingdom facility. Its operations are oriented around a single therapeutic platform rooted in biological, nature-derived mechanisms rather than conventional pharmaceuticals.

Differentiator

Problem solved

Functional benefit

Products and services

  • Natural Biological Wound Care Treatment

Companies that use Biomonde

Customer profile

Ideal customer profiles1 record

Biomonde technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Biomonde partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights2 records

Biomonde competitors and assessment

Company assessment

Broad incumbents

  • Integra LifeSciences: Diversified medical technology company whose Integra Dermal Regeneration Template and wound-care franchise overlap with Biomonde's biologic wound-healing focus. Comparable as a competitor in advanced and regenerative wound therapies.
  • Coloplast: Global wound care and ostomy management company whose Biatain and Comfeel lines compete in the chronic-wound category. Comparable to Biomonde for addressing the same clinician and patient population in wound bed preparation and downstream healing.
  • Mölnlycke Health Care: Established wound care and surgical solutions company best known for Mepitel, Mepilex, and other advanced wound dressings. Comparable to Biomonde for serving the same hospital wound-care buying pathway, including wound bed preparation step.
  • 3M Health Care / Solventum: Large diversified health-care business (recently spun off as Solventum) with a significant advanced wound-care portfolio. Comparable to Biomonde for providing wound-care solutions used in the same clinical pathway, including wound bed preparation and active healing.
  • ConvaTec: Specialist medical products company with a strong advanced wound care and ostomy franchise (Aquacel, Foam dressings). Comparable to Biomonde as a chronic-wound portfolio provider where wound bed preparation is a routine precursor to ConvaTec's dressing usage.
  • Medline Industries: Large private medical supplies manufacturer and distributor with an advanced wound-care line sold to hospitals and post-acute providers. Comparable to Biomonde as a competitor in the wound-care supply chain serving clinicians preparing wound beds.
  • Smith & Nephew: Global medical device company with a leading advanced wound management portfolio (dressings, negative pressure wound therapy, biologics). Comparable to Biomonde as a wound-care provider addressing the same clinical use cases (including wound bed preparation) at much larger scale.

Others

  • Cardinal Health (Medical/Wound Care): Major medical products distributor and manufacturer whose Cardinal Health wound-care portfolio reaches the same hospital and post-acute customers Biomonde targets. Comparable as a channel competitor and adjacent wound-care supplier, rather than as a direct biologic-therapy rival.

Direct peers

  • Organogenesis: Regenerative medicine company selling biologic wound-care products (e.g., Apligraf, Dermagraft) used in chronic wound healing. Directly comparable to Biomonde for offering biologic/living-cell therapies targeted at wound healing rather than only dressings.
  • MiMedx: Regenerative medicine company focused on placental tissue allografts for wound care and surgical recovery. Directly comparable to Biomonde for delivering biologic, tissue-based therapies used in wound management and wound bed preparation.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Biomonde social profiles

Digital presence

Biomonde financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biomonde leadership team

Management profile

Number of profiles

Biomonde funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biomonde M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biomonde

What does Biomonde do?

Biomonde produces a precise, natural, and sustainable biological treatment aimed at wound bed preparation as a step toward wound healing. The company develops and supplies this therapy as its core commercial offering, manufactured and distributed from its Bridgend, United Kingdom facility. Its operations are oriented around a single therapeutic platform rooted in biological, nature-derived mechanisms rather than conventional pharmaceuticals.

When was Biomonde founded?

Biomonde was founded in 2004. It employs 11 to 50 people.

Where is Biomonde based?

Biomonde is headquartered in Bridgend, United Kingdom, in the Europe region.

Who are Biomonde's main competitors?

Broad incumbents on record are Integra LifeSciences, Coloplast, Mölnlycke Health Care, 3M Health Care / Solventum, ConvaTec, Medline Industries and Smith & Nephew. Cardinal Health (Medical/Wound Care) is listed as an others. Direct peers are Organogenesis and MiMedx.

Does Biomonde have an API?

No public API is recorded for Biomonde.

What industry is Biomonde in?

Biomonde's product category is Biosurgical Wound Care Products. Its primary akta.pro industry code is HLAHALAE, Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts), with a secondary code of HLAAAGAG, Wound Healing & Skin Regeneration (advanced dressings, skin substitutes). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals